24
Participants
Start Date
September 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
January 31, 2027
Transcutaneous auricular vagus nerve stimulation
"Transcutaneous auricular vagus nerve stimulation (tVNS) is an emerging therapeutic modality in cardiovascular diseases. tVNS has been shown to exert antiadrenergic and anti-inflammatory effects in humans. Recently, tVNS has been tested in experimental and human POTS, leading to improved autonomic function, reduction of anti-autonomic autoantibodies and inflammatory cytokines.~Parasym device; Parasym Health, London, United Kingdom Frequency: 20Hz, pulse width: 200μs, amplitude will be individually titrated to 1 mA below the level that caused mild discomfort."
Aristotle University Of Thessaloniki
OTHER